TrialCancer2012

AMG 386 in combination with sorafenib in patients with metastatic clear cell carcinoma of the kidney: a randomized, double-blind, placebo-controlled, phase 2 study.

Brian Rini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.